Skip to content

Clinical Study To Evaluate The Efficacy Of Dhatryadi Ghrita In The Raktapradara (Menorrhagia)

A Randomised Controlled Clinical Study To Evaluate The Efficacy Of Dhatryadi Ghrita In The Management Of Raktapradara (Menorrhagia) - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/103427
Enrollment
40
Registered
2026-02-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N920- Excessive and frequent menstruation with regular cycle

Interventions

None listed

Sponsors

Dr Jagtap Aishwarya Prakash
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Pratyatma Lakshana of Raktapradara 2.Excessive bleeding history for more than 2 to 3 consecutive menstrual cycle 3.Subjects willing to sign and give consent

Exclusion criteria

Exclusion criteria: 1.subjects using IUCD and Oral Contraceptive Pills 2.Hb% below 7gm 3.Known cases of Hypertension, Diabetes mellitus, Malignancy, Tuberculosis 4.Known case of Bleeding disorders 5.Known case of Any pathology (e.g. Uterine fibroid, Cervical Polyp, Pelvic inflammatory disease) 6.Post abortal bleeding

Design outcomes

Primary

MeasureTime frame
Effect of Trial Drug on Improvement in the symptoms of RAKTAPRADARA (MENORRHAGIA)Timepoint: 10th day of 1st 2nd and 3rd Menstrual cycle

Secondary

MeasureTime frame
Safety of trial drug & Adverse Drug Reaction Aggravation of Symptoms of RAKTAPRADARA (MENORRHAGIA)Timepoint: 10th day of 1st 2nd & 3rd Menstrual cycle

Countries

India

Contacts

Public ContactDr Jagtap Aishwarya Prakash

SDMTs AMC Post Graduation Centre Terdal

dr.vidyapattar@gmail.com8310160682

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026